British scientists make a significant advance towards a universal vaccine against pneumonia and meningitis caused by ...

A830, a first-in-class KRAS-EGFR Antibody-Targeted Therapy Conjugate ('ATTC”), which is expected to enter clinical trials in H2 2026 - ...

Researchers at the National Institutes of Health made the breakthrough after studying disease-fighting proteins made by the immune system.

We all want thicker hair, a flatter stomach and stronger immune function. And there may be an easy way to get it. We’re talking about nutrient-rich “liquid gold” bovine colostrum, the yellow premilk ...

Purple Biotech (NASDAQ:PPBT) has received a U.S. patent allowance covering tri-specific antibody constructs and methods of use, expanding intellectual property protection around its modular CAPTN-3 ...

A new single-cell map of childhood Crohn’s disease offers a closer look at disease progression and treatment response.

Treeline Biosciences, Inc. ("Treeline") today announced a clinical trial collaboration and supply agreement with Roche (SIX: RO, ROP; OTCQX: RHHBY) to evaluate TLN-121, Treeline's BCL6 degrader, in ...

Teva Pharmaceutical's dreams of a first-in-class autoimmune blockbuster are being kept alive after the Israeli outfit’s ...

AI by itself isn’t enough to develop a compelling drug; the biology also has to check out. The science behind ABS-201 came to ...

In honor of Blood Cancer Awareness Month, this special Director’s Cut episode of Managed Care Cast features a conversation ...

National Institutes of Health (NIH) researchers have discovered rare antibodies that could inform the development of an ...